Waldencast price target lowered to $3 from $4 at Telsey Advisory

Telsey Advisory lowered the firm’s price target on Waldencast (WALD) to $3 from $4 and keeps an Outperform rating on the shares. The moderated annual outlook comes as a disappointment as solid underlying trends are offset by softening international consumption, out of stocks at its brands, and exiting of non-core distribution points at Obagi, the analyst tells investors.

Elevate Your Investing Strategy:

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on WALD:

Disclaimer & DisclosureReport an Issue

Waldencast price target lowered to $2 from $2.40 at TD Cowen Waldencast Reports Strong H1 2025 Growth and Strategic Initiatives Waldencast Acquisition Corp. (WALD) Q2 Earnings Cheat Sheet Waldencast Acquires Novaestiq and U.S. Rights to Saypha® Waldencast acquires Novaestiq Corp., rights to Saypha gels

View Comments